ZNOVInnovator Equity Defined Protection ETF - 1 Yr November
Seeks to provide investors with returns that match the return of the Underlying ETF, up to the upside cap of 6.84%, while providing a buffer against 100% of Underlying ETF losses.
By Innovator ETFs · Launched 2024
0.79%
#4,047 of 5,562 · expensive
$121M
#2,757 of 5,562 · mid-size
+6.7%
1 year
#3,917 of 5,562 · young
Performance
Total-return NAV · USDTotal-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 4 holdings = 100.0% of fundconcentrated
Asset allocation
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsYear-on-year price swings
Worst peak-to-trough loss
Needs 3+ years of history
Needs 3+ years of history
Where to buy
Listing
- Exchange
- Cboe BZX
Full fund details
- Objective
- Seeks to provide investors with returns that match the return of the Underlying ETF, up to the upside cap of 6.84%, while providing a buffer against 100% of Underlying ETF losses.
- Strategy
- Invests primarily in investments providing exposure to the State Street SPDR S&P 500 ETF Trust, aiming to match returns up to a cap of 6.84% while buffering against 100% of losses.
- Inception date
- October 31, 2024
- Fund family
- Innovator ETFs
Similar ETFs
Closest matches by profileOur take
Structural notes on how this fund behaves. Read our guide on the 6 warning signs.
Buffer ETF — downside protection at a cost
Defined-outcome funds cap upside (typically 8–20%) in exchange for partial downside protection (9–30%), priced via options. Fees are materially higher than the underlying index (often 0.70%+ vs 0.03–0.10%). For most pre-retirees, a simple stock/bond mix achieves similar downside behaviour at a fraction of the cost.
Source: Morningstar, 'Defined-Outcome ETFs: Useful or Uneconomic?' (2023)
Why we flagged this: strategy=structured_outcome + structured_outcome_strategy
Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More
What's next?
You've reviewed ZNOV. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19